GeneDx Holdings Corp. Payments of Merger Related Costs, Financing Activities
GeneDx Holdings Corp. (WGS) reported Payments of Merger Related Costs, Financing Activities of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2023-03-16
- GeneDx Holdings Corp. payments of merger related costs, financing activities for the quarter ending 2022-12-31 was $0.00.
- GeneDx Holdings Corp. payments of merger related costs, financing activities for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- GeneDx Holdings Corp. payments of merger related costs, financing activities for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- GeneDx Holdings Corp. payments of merger related costs, financing activities for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- GeneDx Holdings Corp. payments of merger related costs, financing activities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- GeneDx Holdings Corp. payments of merger related costs, financing activities for fiscal 2021 was $51.76M.
- GeneDx Holdings Corp. payments of merger related costs, financing activities for fiscal 2020 was $0.00.
- GeneDx Holdings Corp. payments of merger related costs, financing activities for fiscal 2019 was $0.00.
| Period end | Payments of Merger Related Costs, Financing Activities 3 month | Payments of Merger Related Costs, Financing Activities 6 month | Payments of Merger Related Costs, Financing Activities 9 month | Payments of Merger Related Costs, Financing Activities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $48.98M derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $48.98M derived: sum of 3 quarters · filed 2023-03-16 | $50.51M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $48.98M derived: sum of 2 quarters · filed 2023-03-16 | $50.51M derived: sum of 3 quarters · filed 2023-03-16 | $51.76M 10-K · filed 2023-03-16 |
| 2021-09-30 | $48.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $50.51M derived: sum of 2 quarters · filed 2022-11-14 | $51.76M 10-Q · filed 2022-11-14 | $51.76M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.78M 10-Q · filed 2022-08-15 | $2.78M derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | $1.25M 10-Q · filed 2022-05-12 | $1.25M derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |